{
    "clinical_study": {
        "@rank": "127579", 
        "arm_group": {
            "arm_group_label": "Treatment with CJH1", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the ability of CJH1 to increase the sensitivity of\n      dopamine receptors and thereby reduce symptoms of Parkinson's Disease."
        }, 
        "brief_title": "A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Parkinson's Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient's with Parkinson's disease\n\n        Exclusion Criteria:\n\n          -  Contraindications to study medication"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01684475", 
            "org_study_id": "CJH1 Trial"
        }, 
        "intervention": {
            "arm_group_label": "Treatment with CJH1", 
            "intervention_name": "CJH1  (CLR4001)", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Novel Treatment Parkinson's disease", 
        "lastchanged_date": "September 12, 2012", 
        "location": {
            "contact": {
                "last_name": "Craig Hudson, MD", 
                "phone": "519-524-8323"
            }, 
            "facility": {
                "address": {
                    "city": "Goderich", 
                    "country": "Canada", 
                    "state": "Ontario", 
                    "zip": "N7A 1W5"
                }, 
                "name": "Gateway Rural Health Research"
            }, 
            "investigator": {
                "last_name": "Craig J Hudson, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "A STUDY TO EVALUATE THE EFFICACY OF CJH1 [CLR4001] IN THE TREATMENT OF PARKINSON'S DISEASE", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": "September 2013", 
        "primary_outcome": {
            "description": "Reduced signs and symptoms of Parkinson's disease", 
            "measure": "Reduced signs and symptoms of Parkinson's disease", 
            "safety_issue": "Yes", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01684475"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Alexandra Marine and General Hospital", 
            "investigator_full_name": "Craig Hudson MD", 
            "investigator_title": "Psychiatrist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Alexandra Marine and General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Alexandra Marine and General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}